Cognitive Behavioral Therapy for Suicide Attempt Prevention
Trial Summary
What is the purpose of this trial?
The overall goal for the proposed project is to test the effectiveness of BCBT for the prevention of suicide attempts in a sample of treatment-seeking U.S. military personnel and veterans. The standard null hypothesis will involve tests conducted comparing improvement following BCBT (treatment duration of 12 weeks) to Person-Centered Therapy (PCT). The primary outcome comparisons will include direct markers of suicidality (i.e. suicide, suicide attempts). Secondary outcomes will be suicide ideation and indicators of psychiatric distress (e.g., depression, hopelessness). We also aim to assess several hypothesized psychological and neurocognitive mediators of treatment effects (e.g., wish to live, attentional bias, emotion regulation). Participants will be followed for 2 years posttreatment by independent evaluators blind to treatment condition.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Brief Cognitive Behavioral Therapy (BCBT) for preventing suicide attempts?
Is Cognitive Behavioral Therapy for Suicide Prevention safe for humans?
The research on Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and its variations, like Brief Cognitive Behavioral Therapy (BCBT), primarily focuses on its effectiveness in reducing suicide attempts, particularly among military personnel. While the studies emphasize its efficacy, they do not report any significant safety concerns, suggesting it is generally safe for human use.12678
How is the treatment Brief Cognitive Behavioral Therapy (BCBT) for suicide attempt prevention different from other treatments?
Brief Cognitive Behavioral Therapy (BCBT) is unique because it specifically targets suicidal thoughts and behaviors rather than focusing on underlying mental illnesses. It is a structured, short-term therapy that has been shown to effectively reduce the risk of repeated suicide attempts, making it a preferred option for individuals who have previously attempted suicide.12469
Research Team
Craig J Bryan, PsyD, ABPP
Principal Investigator
Ohio State University
Eligibility Criteria
This trial is for U.S. military personnel and veterans who are at least 18 years old, can understand and speak English, and have had suicidal thoughts with intent to die or a suicide attempt in the last two weeks. It's not for those unable to consent or participate in outpatient treatment due to severe psychiatric conditions like psychosis or mania.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Brief Cognitive Behavioral Therapy (BCBT) or Present-Centered Therapy (PCT) for the prevention of suicide attempts
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Brief Cognitive Behavioral Therapy (BCBT)
- Present-Centered Therapy (PCT)
- Treatment as Usual (TAU)
Brief Cognitive Behavioral Therapy (BCBT) is already approved in United States, European Union for the following indications:
- Suicide prevention
- Reduction of suicidal ideation
- Suicide prevention
- Reduction of suicidal ideation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor
Medical University of South Carolina
Collaborator
Ohio State University
Collaborator
United States Department of Defense
Collaborator
Lowcountry Center for Veterans Research
Collaborator